John Shire

John focuses his corporate and transactional practice on the health care and life sciences industry, as well as other highly regulated sectors. He represents public and private companies in acquisitions, investments, debt financings, joint ventures, commercial contracts, and private placements. John also advises companies in these sectors on strategic mergers and acquisitions and public exit strategies. He also advises private funds on formation, structure, and capital allocation in the health care, life sciences, and digital medicine sectors. John has led several high-profile transactions in the U.S. health care arena and routinely counsels portfolio companies, venture capital funds, and private equity funds on transactional, regulatory, and licensing matters. His clients include biopharma companies, biotech companies, specialty pharmacy suppliers, GPOs, specialty-care providers, and the full range of institutional clinical (Part A) and primary and specialty (Part B) service providers. John counsels clients in transactions and compliance with Medicare, Medicaid, and U.S. Department of Justice initiatives, including CID responses. In addition to transactional and regulatory work, John serves as outside general counsel to innovative entities and has experience representing investment banks and private funds in technology and digital health care deals.

Co-Chair, Cozen O'Connor Health Care & Life Sciences Practice Group

Bucknell University

B.A.

Dickinson School of Law

J.D.